[ORGANIZATION]
Formycon AG
Featured in 3 tracked stories · first seen
Situations
Keytruda biosimilar regulatory developments
2 clusters · 9 sources · last updated
Latest: Zydus Lifesciences receives USFDA inspection observations and biosimilar review acceptance
Formycon AG and Zydus Lifesciences have announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for FYB206 for review. FYB206 is a biosimilar candidate for the onco
Also covered in
-
Formycon and Biocelys partner on biosimilar project FYB286
[BUSINESS] · 2 sources ·